AXS-07 Outperforms Other CGRP-Targeting Gepants in Meta-Analysis

Relative to previously approved therapies like rimegepant, ubrogepant, and zavegepant, AXS-07 resulted in better 2-hour pain relief, sustained pain relief, and reduced use of rescue medications.:

Source: Neurology Read More